Status:
COMPLETED
Multisite Pacing With a Quadripolar Lead
Lead Sponsor:
Abbott Medical Devices
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the effects of multisite left ventricular (LV) biventricular (BiV) pacing on LV hemodynamics in CRT patients. It is hypothesized that the effect of simultaneou...
Eligibility Criteria
Inclusion
- Have a scheduled CRT implantation at the participating clinical study site
- Have NYHA functional class III or IV, ejection fraction less than or equal to 35%, and QRS duration greater than 120ms
- Be undergoing a new St. Jude Medical CRT-D device system (including LV lead) implantation
- Have the ability to provide informed consent for study participation and be willing and able to comply with the prescribed perioperative evaluations
Exclusion
- Have persistent or permanent atrial fibrillation
- Have an intrinsic heart rate of \<50 beats per minute
- Have a recent myocardial infarction within 40 days prior to enrollment
- Have undergone cardiac surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures
- Have had a recent CVA or TIA within 3 months prior to enrollment
- Have had intravenous inotropic support in the last 30 days
- Have ischemic etiology and are unable to tolerate stress echocardiography
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00964938
Start Date
August 1 2009
Last Update
February 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montreal Heart Institute
Montreal, Quebec, Canada